Driving functions in a video simulator in chronic non-malignant pain patients using and not using codeine

European Journal of Pain

Volumn 15, Issue 4, 2011, Pages 409-415

  Nilsen, Halvard K ^a,b   Landrø, Nils I ^a,c   Kaasa, Stein ^a,d   Jenssen, Gunnar D ^e   Fayers, Peter ^a,f   Borchgrevink, Petter C ^a,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Aalesund Hospital   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Chronic pain; Codeine; Driving function; Driving simulator; Opioid; Reaction time; Traffic safety

Indexed keywords

AMITRIPTYLINE; CODEINE;

ABDOMINAL PAIN; ADULT; ARTICLE; CAR DRIVING; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DRIVING ABILITY; DRUG BLOOD LEVEL; EVENING DOSAGE; FEMALE; HEADACHE; HUMAN; LOW DRUG DOSE; MALE; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RESPONSE TIME; RURAL AREA; SIMULATION; SINGLE DRUG DOSE; STIMULUS RESPONSE; URBAN AREA;

ADULT; ANALGESICS, OPIOID; AUTOMOBILE DRIVING; CHRONIC DISEASE; CODEINE; COMPUTER GRAPHICS; COMPUTER SIMULATION; ENVIRONMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PERSONALITY; PERSONALITY TESTS; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; REACTION TIME; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 79954416446     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2010.09.008     Document Type: Article

References (57)

1. Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organisation for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76. (Pubitemid 23073154)
2. Bachs LC, Engeland A, Morland JG, Skurtveit S. The risk of motor vehichle accidents involving drivers with prescriptions for codeine or tramadol. Clin Pharmacol Ther 2009;85:596-9.
3. Babarik P. Automobile accidents and driver reaction pattern. J Appl Psychol 1968;52:49-54.
4. Ball KK, Roenker DL, Wadley WG, Edwards JD, Roth DL, McGwin Jr G, et al. Can high-risk older drivers be identified through performance-based measures in a department of motor vehichles setting? J Am Geriatr Soc 2006;54:77-84.
5. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
6. Brunton LL, Lazo JS, Parker KL. In: Goodman & Gilman's: the pharmacological basis of therapeutics. New York: McGraw-Hill; 2006. p. 580.
7. Byas-Smith MG, Chapman SL, Reed B, Cotsonis G. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain 2005;21:345-52. (Pubitemid 40881145)
8. Chapman SL, Byas-Smith MG, Reed BA. Effect of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain 2002;18(S):83-90.
9. Clay OJ, Wadley VG, Edwards JD, Roth DL, Ball KK. Cumulative meta-analyses of the relationship between useful field of view and driving performance in older adults: current and future implications. Optom Vis Sci 2005;82:724-31. (Pubitemid 41243648)
10. Dagtekin O, Gerbergshagen HJ, Wagner W, Petzke F, Radbruch L, Sabatowski R. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients. Anesth Analg 2007;105:1442-8. (Pubitemid 350303955)
11. Daut RL, Cleeland CS, Flanery RC. Development of the wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210. (Pubitemid 13012221)
12. Dubois S, Bedard M, Weaver B. The association between opioid analgesics and unsafe driving actions preceding fatal crashes. Accident Anal Prev 2010;42:30-7.
13. Eccleston C, Crombez G, Aldrich S, Stannard C. Attention and somatic awareness in chronic pain. Pain 1997;72:209-15. (Pubitemid 27321919)
14. Eccleston C, Crombez G. Pain demands attention. A cognitive-affective model of the interruptive function of pain. Psychol Bull 1999;125:356-66.
15. Engvik H, Føllesdal H. The big five inventory på norsk. Tidsskrift for den norske psykologforening 2005;42:128-9.
16. Eriksen J, Jensen MK, Sjogren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003;106:221-8. (Pubitemid 37505870)
17. Fallon M, Cherny NI, Hanks G. Opioid analgesic therapy. In: Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, editors. Oxford textbook of palliative medicine. 4th ed. Oxford: Oxford University Press; 2010.
18. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numeric rating scale. Pain 2001;94:149-58. (Pubitemid 33016608)
19. Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. J Pain Symptom Manage 2003;25:559-77. (Pubitemid 36637063)
20. Fredheim OM, Kaasa S, Fayers P, Saltnes T, Jordhoy M, Borchgrevink PC. Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients. Acta Anaesthesiol Scand 2008;52:143-8.
21. Gaertner J, Radbruch L, Giesecke T, Gerbershagen H, Petzke F, Ostgathe C, et al. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiol Scand 2006:664-72.
22. Grisart JM, Plaghki LH. Impaired selective attention in chronic pain patients. Eur J Pain 1999;3:325-33. (Pubitemid 30056165)
23. Gormsen L, Rosenberg R, Bach FW, Jensen TS. Depression, anxiety, health-related quality of life and pain in pain patients with chronic fibromyalgia and neuropatic pain. EJP 2010;14:127 [e1-8].
24. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's: the pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. p. 569-620.
25. Hamunen K, Laitinen-Parkkonen P, Paakkari P, Breivik H, Gordh T, Jensen NH, et al. What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 2008;12:705-15.
26. Hart RP, Martelli MF, Zasler ND. Chronic pain and neuropsychological functioning. Neuropsychol Rev 2000;10:131-49.
27. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998;15:185-94. (Pubitemid 28169141)
28. John OP, Srivastava S. The big five trait taxonomy: history, measurement, and theoretical perspectives. In: Pervin LA, John OP, editors. Handbook of personality, theory and research. 2nd ed. New York: The Guilford Press; 1999. p. 102-38.
29. Kahnemann D, Ben-Ishhai R, Lotan M. Relation of a test of attention to road accidents. J Appl Psychol 1973;58:113-5.
30. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS, et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with non-cancer pain. Clin J Pain 2004;20:309-18. (Pubitemid 39108843)
31. Kessels RP, Aleman A, Verhagen WI, van Luijtelaar EL. Cognitive functioning after whiplash injury: a meta-analyses. J Int Neuropsychol Soc 2000;6:271-8. (Pubitemid 30303639)
32. Klepstad P, Loge JH, Borchgrevink PC, Mendoza TR, Cleeland CS, Kaasa S. The Norwegian brief pain inventory questionnaire; translation and validation in cancer pain patients. J Pain Symptom Manage 2002;24:517-25. (Pubitemid 36120427)
33. Lococo KH, Staplin L. Literature review of polypharmacy and older drivers: identifying strategies to collect drug usage and driving functioning among older drivers. Washington (DC): National Highway Traffic Safety Administration Office of Research and Technology; 2006. [20590. Report no. DOT HS 810 558].
34. Menefee LA, Frank ED, Crerand C, Jalali S, Park J, Sanschagrin K, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med 2004;5:42-9. (Pubitemid 38404443)
35. Mihal WL, Barrett GV. Individual differences in perceptual information processing and their relation to automobile accident involvement. J Appl Psychol 1976;61:229-33.
36. O'Hanlon JF. Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 1984;18S1:121-9.
37. Orth M, Duchna HW, Leidag M, Widdig W, Rasche K, Bauer TT, et al. Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy. Eur Res J 2005;26:898-903. (Pubitemid 41632049)
38. Quiding H, Oikarinen V, Sane J, Sjoblad AM. Analgesic efficacy after single and repeated doses of codeine and acetaminophen. J Clin Pharmacol 1984;24:27-34. (Pubitemid 14154711)
39. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiat 2003;64:20-9. (Pubitemid 36182225)
40. Roge J, Pebayle T, El Hannachi S, Muzet A. Effect of sleep deprivation and driving duration on the useful visual field in younger and older subjects during simulator driving. Vision res 2003;43:1465-72. (Pubitemid 36588800)
41. Roge J, Pebayle T, Campagne A, Muzet A. Useful visual field reduction as a function of age and risk of accident in simulated car driving. Invest Ophthalmol Vis Sci 2005;46:1774-9. (Pubitemid 44843616)
42. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term opioid therapy. J Pain Sympt Manage 2000;19:100-8. (Pubitemid 30116799)
43. Strumpf M, Köhler A, Zenz M, Willweber-Strumpf A, Dertwinkel AR, Donner B. Opioids and driving ability. Schmerz 1997;11:233-40. (Pubitemid 27400399)
44. Szlyk JP, Mahler CL, Seiple W, Vajaranant TS, Blair NP, Shahidi M. Relationship of retinal structural and clinical vision parameters to driving performance of diabetic retinopathy patients. J Rehab Res Dev 2004;41:347-58.
45. Tassain V, Attal N, Fletcher D, Brasseur L, Degieux P, Chauvin M, et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003;104:389-400. (Pubitemid 36835907)
46. Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995;346:667-70.
47. Veldhuijzen DS, van Wijck AJ, Wille F, Verster JC, Kenemans JL, Kalkman CJ, et al. Effect of chronic nonmalignant pain on highway driving performance. Pain 2006a;122:28-35.
48. Veldhuijzen DS, van Wijck AJ, Verster JC, Kenemans JL, Kalkman CJ, Olivier B, et al. Acute and subchronic effects of amitriptyline 25 mg on actual driving in chronic neuropathic pain patients. J Psychoph 2006b;20:782-8. (Pubitemid 44622742)
49. Verster JP, Volkerts ER, Verbaten MN. The predictive value of driving-related laboratory tests and subjective assessments to on-the-road driving ability. J Psychoph 2002;3(Suppl):A62.
50. Verster JC, Veldhuijzen DS, Volkerts ER. Is it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal traffic. Curr Psych Rev 2005;1:215-25.
51. Verster JC, Veldhuijzen DS, Volkerts ER. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain 2006;22:499-504. (Pubitemid 44350461)
52. Wade JB, Hart RP. Attention and the stages of pain processing. Pain Med 2002;3:30-8. (Pubitemid 34520525)
53. Wilcox RA, Reviews Owen H. Variable cytochrome P450 2D6 expression and metabolism of codeine and other opioids. Anaesth Intensive Care 2000;28:611-9.
54. Zacny JP. Should people taking opioids for medical reasons be allowed to work and drive? Addiction 1996;91:1581-4.
55. Zacny JP, Gutierrez S, Bolbolan SA. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users. Drug Alc Depend 2005;78:243-52. (Pubitemid 40694046)
56. Zacny JP. Chronic pain and driving: proceed with caution. Editorial Pain 2006;122:6-7.
57. Mørland J. Trafikk, risikofylt arbeid og legemidler. In: Vilberg A, editor, Norwegian drug and therapeutic formulary for health personnel, 2008. p. 1593-4. Available 15th of July 2009 at 〈http://WWW.Legemiddelhandboka. no〉.